A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2010
At a glance
- Drugs Dasabuvir; Ketoconazole
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 26 Apr 2009 Pharmacokinetc results reported at the 44th Annual Meeting of the European Association for the Study of the Liver.
- 04 Mar 2009 Actual patient number changed from 36 to 45 as reported by ClinicalTrials.gov.
- 04 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History